Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Web site

<< Previous

Bullboard Posts

Next >>

Comment by NSX001on May 10, 2022 9:29am

149 Views

Post# 34669949

RE:RE:RE:RE:RE:RE:Web site

Good morning Normandt1965,

I don't believe it makes any difference which coloumn you look at. I don't think it moves closer to the front of the Q and stays there, because it appears to go forward and backward. We're in the Q and we'll recieve our DIN # when there done.
I don't understand why it's taking this long, this is not a newly developed medication that needs long stringent testing, it's an existing product, that's already being used in other countries..

NSX001

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario